Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 醫學院
  3. 藥學專業學院
  4. 藥學系
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/65703
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor李水盛(Shoei-Sheng Lee)
dc.contributor.authorJui-Wei Liangen
dc.contributor.author梁芮瑋zh_TW
dc.date.accessioned2021-06-17T00:00:11Z-
dc.date.available2015-08-01
dc.date.copyright2012-09-19
dc.date.issued2012
dc.date.submitted2012-07-16
dc.identifier.citation1. Dev, S., Zerumbone, a monocyclic sesquiterpene ketone. Tetrahedron 1960, 8 (3-4), 171-180.
2. Hall, S. R.; Nimgirawath, S.; Raston, C. L.; Sittatrakul, A.; Thadaniti, S.; Thirasasana, N.; White, A. H., Crystal-structure of zerumbone [(2E,6E,10E)- 2,6,9,9-tetramethylcycloundeca-2,6,10-trien-1-one]. Australian Journal of Chemistry 1981, 34 (10), 2243-2247.
3. Dai, J. R.; Cardellina, J. H.; McMahon, J. B.; Boyd, M. R., Zerumbone, an HIV-inhibitory and cytotoxic sesquiterpene of Zingiber aromaticum and Z.zerumbet. Natural Product Letters 1997, 10 (2), 115-118.
4. Murakami, A.; Takahashi, M.; Jiwajinda, S.; Koshimizu, K.; Ohigashi, H., Identification of zerumbone in Zingiber zerumbet Smith as a potent inhibitor of 12-O-tetradecanoylphorbol-13-acetate-induced Epstein-Barr virus activation. Bioscience, Biotechnology, and Biochemistry 1999, 63 (10), 1811-1812.
5. Murakami, A.; Tanaka, T.; Lee, J. Y.; Surh, Y. J.; Kim, H. W.; Kawabata, K.; Nakamura, Y.; Jiwajinda, S.; Ohigashi, H., Zerumbone, a sesquiterpene in subtropical ginger, suppresses skin tumor initiation and promotion stages in ICR mice. International Journal of Cancer 2004, 110 (4), 481-90.
6. Kirana, C.; McIntosh, G. H.; Record, I. R.; Jones, G. P., Antitumor activity of extract of Zingiber aromaticum and its bioactive sesquiterpenoid zerumbone. Nutrition and Cancer 2003, 45 (2), 218-225.
7. Sakinah, S. A.; Handayani, S. T.; Hawariah, L. P., Zerumbone induced apoptosis in liver cancer cells via modulation of Bax/Bcl-2 ratio. Cancer cell international 2007, 7, 4.
8. Abdel Wahab, S. I.; Abdul, A. B.; Alzubairi, A. S.; Mohamed Elhassan, M.; Mohan, S., In vitro ultramorphological assessment of apoptosis induced by zerumbone on HeLa. Journal of Biomedicine and Biotechnology 2009, 2009, 769568.
9. Taha, M. M. E.; Abdul, A. B.; Abdullah, R.; Ibrahim, T. A. T.; Abdelwahab, S. I.; Mohan, S., Potential chemoprevention of diethylnitrosamine-initiated and 2-acetylaminofluorene-promoted hepatocarcinogenesis by zerumbone from the rhizomes of the subtropical ginger (Zingiber zerumbet). Chemico-Biological Interactions 2010, 186 (3), 295-305.
10. Xian, M. J.; Ito, K.; Nakazato, T.; Shimizu, T.; Chen, C. K.; Yamato, K.; Murakami, A.; Ohigashi, H.; Ikeda, Y.; Kizaki, M., Zerumbone, a bioactive sesquiterpene, induces G2/M cell cycle arrest and apoptosis in leukemia cells via a Fas- and mitochondria-mediated pathway. Cancer Science 2007, 98 (1), 118-126.
11. Chien, T. Y.; Chen, L. G.; Lee, C. J.; Lee, F. Y.; Wang, C. C., Anti-inflammatory constituents of Zingiber zerumbet. Food Chemistry 2008, 110 (3), 584-589.
12. Sulaiman, M. R.; Perimal, E. K.; Akhtar, M. N.; Mohamad, A. S.; Khalid, M. H.; Tasrip, N. A.; Mokhtar, F.; Zakaria, Z. A.; Lajis, N. H.; Israf, D. A., Anti-inflammatory effect of zerumbone on acute and chronic inflammation models in mice. Fitoterapia 2010, 81 (7), 855-858.
13. Kitayama, T., Attractive Reactivity of a Natural Product, Zerumbone. Bioscience, Biotechnology, and Biochemistry 2011, 75 (2), 199-207.
14. Huang, T.-C., Flora of Taiwan. 2 ed.; Editorial Committee of Flora of Taiwan and Department of Botany, National Taiwan University: Taipei, Taiwan, 2000, 5, 723.
15. Yob, N. J.; Jofrry, S. M.; Affandi, M. M. R. M. M.; Teh, L. K.; Salleh, M. Z.; Zakaria, Z. A., Zingiber zerumbet (L.) Smith: A review of its ethnomedicinal, chemical, and pharmacological uses. Evidence-based Complementary and Alternative Medicine 2011, 1-12.
16. Catalano, S.; Cioni, P. L.; Flamini, G.; Defeo, V.; Morelli, I., Chemical investigation of the aerial parts of Mutisia acuminata. International Journal of Pharmacognosy 1995, 33 (1), 73-74.
17. Rout, K. K.; Mishra, S. K.; Sherma, J., Development and validation of an HPTLC method for analysis of zerumbone, the anticancer marker from Zingiber zerumbet. Acta Chromatographica 2009, 21 (3), 443-452.
18. Matthes, H. W. D.; Luu, B.; Ourisson, G., Chemistry and biochemistry of Chinese drugs. 6. Cytotoxic components of Zingiber zerumbet, Curcuma zedoaria and Curcuma domestica. Phytochemistry 1980, 19 (12), 2643-2650.
19. Chung, I. M.; Kim, M. Y.; Park, W. H.; Moon, H. I., Histone deacetylase inhibitors from the rhizomes of Zingiber zerumbet. Pharmazie 2008, 63 (10), 774-776.
20. Min, H. Y.; Kim, M. S.; Jang, D. S.; Park, E. J.; Seo, E. K.; Lee, S. K., Suppression of lipopolysaccharide-stimulated inducible nitric oxide synthase (iNOS) expression by a novel humulene derivative in macrophage cells. International Immunopharmacology 2009, 9 (7-8), 844-849.
21. Usia, T.; Iwata, H.; Hiratsuka, A.; Watabe, T.; Kadota, S.; Tezuka, Y., Sesquiterpenes and flavonol glycosides from Zingiber aromaticum and their CYP3A4 and CYP2D6 inhibitory activities. Journal of Natural Products 2004, 67 (7), 1079-1083.
22. Bhuiyan, M. N. I.; Chowdhury, J. U.; Begum, J., Chemical investigation of the leaf and rhizome essential oils of Zingiber zerumbet (L.) Smith from Bangladesh. Bangladesh Journal of Pharmacology 2009, 4 (1), 9-12.
23. Damodara.N. P.; Dev, S., Studies in Sesquiterpenes .37. Sesquiterpenoids from Essential Oil of Zingiber zerumbet Smith. Tetrahedron 1968, 24 (11), 4113-4122.
24. Kader, M. G.; Habib, M. R.; Nikkon, F.; Yeasmin, T.; Rahid, M. A.; Rahman M. M.; Gibbons, S., Zederone from the rhizomes of Zingier zerumbet and its anti-staphylococcal activity. Boletinlatino Americanoy del caribe de plantas Medicinales y aromaticas 2010, 9 (1), 63–68.
25. Varier, N. S., Chemical examination of the rhizomes of Zingiber zerumbet Smith. Proceedings of the Indian Academy of Sciences A 1944, 20 (5), 257-260.
26. Ahmad, U. K.; Sirat, H. M.; Sanagi, M. M.; Smith, R. M., Supercritical-fluid extraction and capillary gas-chromatography of the rhizomes of Z. zerumbet. Journal of Microcolumn Separations 1994, 6 (1), 27-32.
27. Jang, D. S.; Seo, E. K., Potentially bioactive two new natural sesquiterpenoids from the rhizomes of Zingiber zerumbet. Archives of Pharmacal Research 2005, 28 (3), 294-296.
28. Jang, D. S.; Han, A. R.; Park, G.; Jhon, G. J.; Seo, E. K., Flavonoids and aromatic compounds from the rhizomes of Zingiber zerumbet. Archives of Pharmacal Research 2004, 27 (4), 386-389.
29. Ruslay, S.; Abas, F.; Shaari, K.; Zainal, Z.; Maulidiani; Sirat, H.; Israf, D. A.; Lajis, N. H., Characterization of the components present in the active fractions of health gingers (Curcuma xanthorrhiza and Zingiber zerumbet) by HPLC-DAD-ESIMS. Food Chemistry 2007, 104 (3), 1183-1191.
30. Masuda, T.; Jitoe, A.; Kato, S.; Nakatani, N., Acetylated flavonol glycosides from Zingiber zerumbet. Phytochemistry 1991, 30 (7), 2391-2392.
31. Oesterling, J. E.; Jacobsen, S. J.; Chute, C. G.; Guess, H. A.; Girman, C. J.; Panser, L. A.; Lieber, M. M., Serum prostate-specific antigen in a community-based population of healthy-men-establishment of age-specific reference ranges. JAMA-The Journal of the American Medical Association 1993, 270 (7), 860-864.
32. Gleason, D. F., Histological grading and clinical staging of prostatic carcinoma. In Tannenbaum M, ed: Urological Pathology: The Prostate 1977, 171-197.
33. http://www.cancer.gov/cancertopics/pdq/treatment/prostate/Patient.
34. Ghosh, A.; Wang, Y. N.; Klein, E.; Heston, W. D. W., Novel role of prostate-specific membrane antigen in suppressing prostate cancer invasiveness. Cancer Research 2005, 65 (3), 727-731.
35. Pulukuri, S. M.; Gondi, C. S.; Lakka, S. S.; Jutla, A.; Estes, N.; Gujrati, M.; Rao, J. S., RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo. The Journal of Biological Chemistry 2005, 280 (43), 36529-40.
36. Songsiang, U.; Pitchuanchom, S.; Boonyarat, C.; Hahnvajanawong, C.; Yenjai, C., Cytotoxicity against cholangiocarcinoma cell lines of zerumbone derivatives. European Journal of Medicinal Chemistry 2010, 45 (9), 3794-3802.
37. (a) Lu, J. H.; Tu, G. Z.; Zhao, Y. Y.; Lv, Y.; Liu, L. Y.; Wu, Y. S., Spectral assignments and reference data - Structural determination of novel terpenes from Buddleia lindleyana. Magnetic Resonance in Chemistry 2004, 42 (10), 893-897; (b) Kitayama, T.; Yamamoto, K.; Utsumi, R.; Takatani, M.; Hill, R. K.; Kawai, Y.; Sawada, S.; Okamoto, T., Chemistry of zerumbone. 2. Regulation of ring bond cleavage and unique antibacterial activities of zerumbone derivatives. Bioscience, Biotechnology, and Biochemistry 2001, 65 (10), 2193-2199.
38. Nakatani, N.; Jitoe, A.; Masuda, T.; Yonemori, S., Flavonoid constituents of Zingiber zerumbet Smith. Agricultural and Biological Chemistry Tokyo 1991, 55 (2), 455-460.
39. Kitayama, T.; Yokoi, T.; Kawai, Y.; Hill, R. K.; Morita, M.; Okamoto, T.; Yamamoto, Y.; Fokin, V. V.; Sharpless, K. B.; Sawada, S., The chemistry of zerumbone. Part 5: Structural transformation of the dimethylamine derivatives. Tetrahedron 2003, 59 (26), 4857-4866.
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/65703-
dc.description.abstract薑科薑屬植物─薑花(Zingiber zerumbet Smith)是一種廣泛為熱帶國家所用之香料食材與藥材。近年研究發現其根莖成份具抗腫瘤、抗白血病、抗發炎、抗菌、治療失智症、鎮痛等活性。其主成分球薑酮(zerumbone)具有多種抗癌活性,且其結構具高度化學、位置與立體選擇性(chemo-, regio-, and stereoselectivity),為一個有潛力的天然物,值得進行其衍生物之活性研究。因此本研究擬大量分離球薑酮,以之為起始物製備一系列含氮衍生物,以探討其抗癌活性。
  本研究將薑花乾燥根莖以加熱乙醇萃取,進行極性分割得二氯甲烷、正丁醇和水可溶部分,其中二氯甲烷可溶部分經初步分離,除得到大量球薑酮(2)外,另得到兩個倍半萜類(1, 3)與兩個黃酮類(4, 5)化合物。以2為起始物,經:(1) Michael addition選擇性在C-3接上不同之烷化胺基得到化合物Ia-g;(2)位置選擇之C-10雙鍵氫化反應得到化合物IIa-d;(3) C-1羰基還原反應得到化合物IIIa-d;(4) C-6、C-10雙鍵之完全氫化反應得到化合物IVa-d。另外,利用具光學活性之羧酸進行消旋產物Id之光學分割,其光學純度以核磁共振氫譜分析監測,最後以X-ray單晶繞射確定(+)-Id之絕對立體結構為2S, 3S-。
  將化合物進行荷爾蒙非依賴型之前列腺癌細胞(PC-3)之抑制活性測試,結果顯示球薑酮之活性最佳(IC50 14.0 μM),而衍生物之活性皆較低。其中側鏈為丙烷胺基之化合物Id、IIc、IVc與同系列之產物相較下,有較高的抑制活性。而C-1羰基還原產物之細胞毒性則普遍較差,指出C-3烷化胺基之碳鏈長度與C-1羰基會影響抗前列腺癌活性。此外,球薑酮骨架化合物對甲型葡萄糖水解酶幾乎無抑制活性,顯示此類化合物具有標的選擇性。
zh_TW
dc.description.abstractZingiber zerumbet Smith is widely used as a spice and ethnomedicine in tropic areas. Recent studies have revealed the constituents of its rhizome to possess various bioactivities, including antitumor, antileukemia, antiinflammatory, antibacteria, antinociceptive, and antidementia. The major component zerumbone (2) being responsible for cytotoxicity against several cancer cell lines is a potential natural product with structural chemo-, regio-, and stereoselectivity and its derivatives are worth undertaking bioactivity study. Thus, the aim of this study was to isolate large amount of 2 for preparing a series of amino-zerumbone derivatives and to investigate their anticancer activity.
   The EtOH extract of the dried rhizome was further divided into fractions soluble in CH2Cl2, n-BuOH and H2O. From the CH2Cl2 layer, two sesquiterpenes (1, 3) and two flavonoids (4, 5) in addition to the major 2 were isolated. Starting from 2, 3-alkylamino derivatives (Ia-g) were prepared via Michael addition, followed by selective hydrogenation to give IIa-d, NaBH4 reduction to give IIIa-d, and exhaustive hydrogenation to yield IVa-d. The racemic Id was further resolved optically with the aid of (+)-di-O-4-toluoyl-D-tartaric acid. The optical purity was examined by 1H NMR analysis. The 2S, 3S- absolute configuration of (+)-Id was determined by single crystal X-ray diffraction on its tartaric acid salt.
  The cytotoxicity of these derivatives against human hormone refractory prostate cancer cell line (PC-3) through SRB assay was evaluated. Of these, 2 is the most active one (IC50 14.0 μM). In addition, compounds Id, IIc and IVc with a 3-propylamino group revealed higher cytotoxicity than other 3-alkylamino derivatives. In general, the products void of C-1 carbonyl group exhibit poorest activity. These results indicated that the length of C-3 aminoalkyl side chain and C-1 carbonyl function will affect the cytotoxicity against prostate cancer. Compounds with zerumbone scaffold are almost inactive against α-glucosidase, indicating that such compounds possess target selectivity.
en
dc.description.provenanceMade available in DSpace on 2021-06-17T00:00:11Z (GMT). No. of bitstreams: 1
ntu-101-R99423005-1.pdf: 4016008 bytes, checksum: 9af70fb6ceaf3c3acfa8b73bf09ef44f (MD5)
Previous issue date: 2012
en
dc.description.tableofcontents目錄
口試委員會審定書 i
誌謝 ii
中文摘要 iii
Abstract iv
表目錄 (List of Tables) xi
流程目錄 (List of Schemes) xii
圖及光譜圖目錄 (List of Figures and Spectra Appendices) xiii
辭彙 (Glossary) xvii
第一章 緒論 1
1.1 Zerumbone介紹 1
1.2 Zerumbone之生物活性研究 1
1.3 Zerumbone之化學衍生發展 3
1.4 薑科植物薑花之簡介 7
1.5 薑科植物薑花成份之文獻研究 9
1.6 前列腺癌簡介 15
1.6.1 前列腺癌(Prostate cancer) 15
1.6.2 前列腺癌的確診、徵狀與病程 15
1.6.3 前列腺癌的治療 17
1.7 研究目的 19
第二章 實驗結果與討論 21
2.1 薑花根莖之成份分離與結構解析 21
2.1.1 α-Humulene (1)之結構解析 22
2.1.2 Zerumbone (2)之結構解析 23
2.1.3 Zerumbone epoxide (3)之結構解析 25
2.1.4 3-O-Methyl-kaempferol (4)之結構解析 26
2.1.5 Kaempferol-3-O-(3,4-di-O-acetyl)-α-L-rhamnopyranoside (5)之結構解析 28
2.2 Zerumbone之結構修飾研究 30
2.2.1 化合物Ia-g 31
2.2.1.1 加熱與微波條件下之共軛加成反應 33
2.2.1.2 化合物Id光學活性研究 34
2.2.2 化合物IIa-d 39
2.2.3 化合物IIIa-d 40
2.2.4 化合物IVa-d 42
2.3 藥物活性測試 43
2.3.1 抗前列腺癌細胞(PC-3)毒性試驗結果與討論 43
2.3.2 甲型葡萄糖水解酶(α-glucosidase)之活性結果與討論 44
2.4 結論 46
第三章 實驗方法 47
3.1 儀器與材料 47
3.1.1 理化性質測定儀器 47
3.1.2 成份分離之儀器及材料 47
3.1.3 溶劑及試藥 48
3.1.4 抗前列腺癌細胞PC-3之活性試驗所用試劑與儀器 49
3.1.5 甲型葡萄糖水解酶之活性試驗所用試劑與儀器 49
3.2 薑花根莖成份之萃取分離 49
3.2.1化合物1-5之分離 50
3.2.2化合物2之大量分離 51
3.3 薑花化合物1-5之物理數據 52
3.4 Zerumbone衍生物之製備與物理數據 54
3.4.1 化合物Ia-g之製備 54
3.4.1.1 (±)-(6E,10E)-3-Amino-2,6,9,9-tetramethylcycloundeca-6,10-dien-1-one (Ia)之製備 54
3.4.1.2 (±)-(6E,10E)-3-Methylamino-2,6,9,9-tetramethylcycloundeca-6,10-dien- 1-one (Ib)之製備 56
3.4.1.3 (±)-(6E,10E)-3-Ethylamino-2,6,9,9-tetramethylcycloundeca-6,10-dien- 1-one (Ic)之製備 57
3.4.1.4 (±)-(6E,10E)-3-Propylamino-2,6,9,9-tetramethylcycloundeca-6,10-dien- 1-one (Id)之製備 58
3.4.1.5 (2S,3S,6E,10E)-3-Propylamino-2,6,9,9-tetramethylcycloundeca-6,10- dien-1-one (+)-di-O-4-toluoyl-D-tartaric acid salt, ((+)-Id•(+)-DDTA)之製備 59
3.4.1.6 (±)-(6E,10E)-3-Butylamino-2,6,9,9-tetramethylcycloundeca-6,10-dien- 1-one (Ie)之製備 60
3.4.1.7 (±)-(6E,10E)-3-Benzylamino-2,6,9,9-tetramethylcycloundeca-6,10- dien-1-one (If)之製備 62
3.4.1.8 (±)-(6E,10E)-3-(N-Acetylamino)-2,6,9,9-tetramethylcycloundeca-6,10- dien-1-one (Ig)之製備 63
3.4.2 化合物IIa-d之製備 64
3.4.2.1 (±)-(6E)-3-Amino-2,6,9,9-tetramethylcycloundeca-6-en-1-one (IIa)之物理數據 64
3.4.2.2 (±)-(6E)-3-Ethylamino-2,6,9,9-tetramethylcycloundeca-6-en-1-one (IIb)之物理數據 65
3.4.2.3 (±)-(6E)-3-Propylamino-2,6,9,9-tetramethylcycloundeca-6-en-1-one (IIc)之物理數據 65
3.4.2.4 (±)-(6E)-3-Butylamino-2,6,9,9-tetramethylcycloundeca-6-en-1-one (IId)之物理數據 66
3.4.3 化合物IIIa-d之製備 67
3.4.3.1 (±)-(6E,10E)-3-Amino-2,6,9,9-tetramethylcycloundeca-6,10-dienol (IIIa)之物理數據 67
3.4.3.2 (±)-(6E,10E)-3-Ethylamino-2,6,9,9-tetramethylcycloundeca-6,10-dienol (IIIb)之物理數據 68
3.4.3.3 (±)-(6E,10E)-3-Propylamino-2,6,9,9-tetramethylcycloundeca-6,10-dienol (IIIc)之物理數據 69
3.4.3.4 (±)-(6E,10E)-3-Butylamino-2,6,9,9-tetramethylcycloundeca-6,10-dienol (IIId)之物理數據 70
3.4.4 化合物IVa-d之製備 70
3.4.4.1 (±)-3-Amino-2,6,9,9-tetramethylcycloundeca-1-one (IVa)之物理數據 71
3.4.4.2 (±)-3-Ethylamino-2,6,9,9-tetramethylcycloundeca-1-one (IVb)之物理數據 71
3.4.4.3 (±)-3-Propylamino-2,6,9,9-tetramethylcycloundeca-1-one (IVc)之物理數據 72
3.4.4.4 (±)-3-Butylamino-2,6,9,9-tetramethylcycloundeca-1-one (IVd)之物理數據 73
3.5 前列腺癌細胞(PC-3)生長抑制的測定(Sulforhodamine assay, SRB assay) 74
3.5.1 原理 74
3.5.2 實驗方法 74
3.6 甲型葡萄糖水解酶之活性試驗(α-Glucosidase inhibition assay) 75
3.6.1 原理 75
3.6.2 實驗方法 75
3.6.2.1 試劑配製 75
3.6.2.2 實驗步驟 76
參考文獻 78
dc.language.isozh-TW
dc.subject球薑酮zh_TW
dc.subject細胞毒殺性zh_TW
dc.subject前列腺癌zh_TW
dc.subject含胺球薑酮衍生物zh_TW
dc.subject甲型葡萄糖水解&#37238zh_TW
dc.subjectZerumboneen
dc.subjectamino-zerumbone derivativesen
dc.subjectprostate canceren
dc.subjectcytotoxicityen
dc.subjectα-glucosidaseen
dc.titleZerumbone衍生物之製備與生物活性研究zh_TW
dc.titlePreparation and Bioactivity Studies of Zerumbone Derivativesen
dc.typeThesis
dc.date.schoolyear100-2
dc.description.degree碩士
dc.contributor.oralexamcommittee顧記華(Jih-Hwa Guh),陳繼明(Chi-Ming Chen)
dc.subject.keyword球薑酮,含胺球薑酮衍生物,前列腺癌,細胞毒殺性,甲型葡萄糖水解&#37238,zh_TW
dc.subject.keywordZerumbone,amino-zerumbone derivatives,prostate cancer,cytotoxicity,α-glucosidase,en
dc.relation.page144
dc.rights.note有償授權
dc.date.accepted2012-07-17
dc.contributor.author-college醫學院zh_TW
dc.contributor.author-dept藥學研究所zh_TW
顯示於系所單位:藥學系

文件中的檔案:
檔案 大小格式 
ntu-101-1.pdf
  未授權公開取用
3.92 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved